{"disease":{"id":"human-papillomavirus","name":"Human Papillomavirus","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":13},"drugs":{"marketed":[{"drug_id":"vaccine-administration","indication_name":"Human Papillomavirus","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vaccine Support Cp","generic_name":"Vaccine administration","company_name":"Women and Infants Hospital of Rhode Island","drug_phase":"marketed","molecular_target":"unknown","drug_class":"vaccine","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (immunocompromised)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (pregnancy)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (adolescent)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (adult)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (immunocompromised)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (pregnancy)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (adolescent)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":10,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05365048","title":"Provider Recommendation and HPV Vaccination","phase":"NA","overall_status":"RECRUITING","enrollment_count":301201,"lead_sponsor_name":"Kaiser Permanente","has_results":false},{"nct_id":"NCT01078220","title":"Observational Surveillance Study to Detect Potential Safety Signals in Patients Who Have Had at Least One Dose of GARDASIL™ (V501-031)","phase":"","overall_status":"COMPLETED","enrollment_count":189629,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04576962","title":"County Level Correlates of HPV Vaccine Series Completion Among Children Ages 11-14 Years in Indiana","phase":"","overall_status":"COMPLETED","enrollment_count":122152,"lead_sponsor_name":"Indiana University","has_results":false},{"nct_id":"NCT05536674","title":"SMS Reminders to Strengthen Demand for HPV Vaccination in Georgia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":55176,"lead_sponsor_name":"The Behavioural Insights Team","has_results":false},{"nct_id":"NCT01077856","title":"GARDASIL™ Vaccine Impact in Population Study (V501-033)","phase":"","overall_status":"COMPLETED","enrollment_count":54516,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04371887","title":"Comparing Strategies for Implementing Primary HPV Screening","phase":"NA","overall_status":"UNKNOWN","enrollment_count":45000,"lead_sponsor_name":"Chun Chao","has_results":false},{"nct_id":"NCT06557954","title":"Cervical Cytology DNA Methylation for Cervical Cancer Screening","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":30000,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT03180034","title":"Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Study","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":27945,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03726151","title":"Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs","phase":"NA","overall_status":"UNKNOWN","enrollment_count":17000,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT04226313","title":"Self-sampling for Non-attenders to Cervical Cancer Screening","phase":"NA","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"The Institute of Molecular and Translational Medicine, Czech Republic","has_results":false},{"nct_id":"NCT04746872","title":"Alinity m HR HPV Specimen Collection Study From Women Undergoing Routine Cervical Cancer Screening","phase":"","overall_status":"COMPLETED","enrollment_count":14935,"lead_sponsor_name":"Abbott Molecular","has_results":false},{"nct_id":"NCT00543543","title":"Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":14840,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT07200414","title":"Strengthening HPV Vaccination and Adolescent Health Research Program in Nigeria (SHARP)","phase":"NA","overall_status":"COMPLETED","enrollment_count":12654,"lead_sponsor_name":"Johns Hopkins Bloomberg School of Public Health","has_results":false},{"nct_id":"NCT05932576","title":"A Multicenter Cohort Study Assessing the Efficacy and Adverse Effects of HPV Vaccination in Chinese Women","phase":"","overall_status":"UNKNOWN","enrollment_count":12000,"lead_sponsor_name":"Fujian Maternity and Child Health Hospital","has_results":false},{"nct_id":"NCT04646954","title":"DNA Methylation Testing for the Screening of Uterine Cervical Lesion","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":12000,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT05668572","title":"A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":12000,"lead_sponsor_name":"Beijing Health Guard Biotechnology, Inc","has_results":false},{"nct_id":"NCT05309122","title":"Cervical Cancer Screening Strategies","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT06815939","title":"Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"DL Analytics","has_results":false},{"nct_id":"NCT03961178","title":"A Cohort Study for the Following up of Conization","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT00867464","title":"Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":8670,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05237947","title":"Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT02653118","title":"Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":4453,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT00090220","title":"A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3819,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT01062074","title":"GARDASIL Reexamination Study (V501-059)","phase":"","overall_status":"COMPLETED","enrollment_count":3605,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04927650","title":"Prevention and Early Detection of Cervical Cancer Through Self-Administered Screening","phase":"","overall_status":"RECRUITING","enrollment_count":3200,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT05662020","title":"A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2750,"lead_sponsor_name":"Beijing Health Guard Biotechnology, Inc","has_results":false},{"nct_id":"NCT03898167","title":"Prospective Evaluation of Self-Testing to Increase Screening","phase":"NA","overall_status":"COMPLETED","enrollment_count":2474,"lead_sponsor_name":"Baylor College of Medicine","has_results":true},{"nct_id":"NCT06708351","title":"Enhancing Cervical Cancer Screening and Treatment in Women Living With HIV in Kenya, the ENHANCE LINKAge Trial","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":2280,"lead_sponsor_name":"Emory University","has_results":false},{"nct_id":"NCT06598475","title":"Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents","phase":"NA","overall_status":"RECRUITING","enrollment_count":2142,"lead_sponsor_name":"The University of Texas Health Science Center, Houston","has_results":false},{"nct_id":"NCT04000503","title":"Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge)","phase":"NA","overall_status":"COMPLETED","enrollment_count":2019,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT06926062","title":"Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1900,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":false},{"nct_id":"NCT07104240","title":"A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":1836,"lead_sponsor_name":"Emory University","has_results":false},{"nct_id":"NCT00092547","title":"A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1781,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05932563","title":"Study on the Epidemiological Characteristics of Female HPV Vaccination in China","phase":"","overall_status":"UNKNOWN","enrollment_count":1700,"lead_sponsor_name":"Fujian Maternity and Child Health Hospital","has_results":false},{"nct_id":"NCT01984697","title":"A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1518,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT02897427","title":"Throat and Other HPV-Related Cancers in Men: Identifying Them Early","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Baylor College of Medicine","has_results":false},{"nct_id":"NCT00804466","title":"Human Papillomavirus Epidemiology in Nigeria","phase":"NA","overall_status":"COMPLETED","enrollment_count":1466,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06213051","title":"Comparison of Self-collection Using Dry Compared to Wet Swabs for HPV Detection","phase":"","overall_status":"UNKNOWN","enrollment_count":1306,"lead_sponsor_name":"Foundation for Innovative New Diagnostics, Switzerland","has_results":false},{"nct_id":"NCT03429413","title":"Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1296,"lead_sponsor_name":"University of Florida","has_results":false},{"nct_id":"NCT06207175","title":"A Study to Evaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) Vaccine","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":1260,"lead_sponsor_name":"Beijing Health Guard Biotechnology, Inc","has_results":false},{"nct_id":"NCT00988884","title":"A Study of V503 Given Concomitantly With Menactra™ and Adacel™ in 11 to 15 Year Olds (V503-005)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1241,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT03728881","title":"Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1240,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT03158220","title":"Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1212,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04472377","title":"HPV Typing Between Self- and Physician-sampled","phase":"NA","overall_status":"COMPLETED","enrollment_count":1210,"lead_sponsor_name":"Hygeia Touch Inc.","has_results":true},{"nct_id":"NCT05057312","title":"Promoting HPV Vaccination Among Young Adults in Texas","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1200,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT04333212","title":"HPV Genotyping by DR. HPV Genotyping in Vitro Diagnostic Device (IVD) Kit in Exfoliated Cells of the Uterine Cervix","phase":"NA","overall_status":"COMPLETED","enrollment_count":1103,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT04133610","title":"HPVPro Study: Comparison of HPV Detection in Clinician-collected Cervical Swabs and Self-sampled Cervicovaginal Swabs","phase":"NA","overall_status":"COMPLETED","enrollment_count":1044,"lead_sponsor_name":"The Institute of Molecular and Translational Medicine, Czech Republic","has_results":false},{"nct_id":"NCT03345875","title":"Feasibility and Acceptability of HPV Self-Collection Cervical Cancer Screening and Treatment in Botswana","phase":"NA","overall_status":"COMPLETED","enrollment_count":1022,"lead_sponsor_name":"Jhpiego","has_results":false},{"nct_id":"NCT03111251","title":"Multi-component Interventions to Increase HPV Vaccination in a Network of Pediatric Clinics","phase":"NA","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"The University of Texas Health Science Center, Houston","has_results":false},{"nct_id":"NCT07275333","title":"Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine","phase":"NA","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Karolinska Institutet","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}